Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check5 days agoChange DetectedThe page's related topics section was updated to remove 'Melanoma' and MedlinePlus Genetics; no core content or user-facing functionality was changed. To avoid being alerted by small changes, set an alert condition below.SummaryDifference0.2%

- Check12 days agoChange DetectedMelanoma is now listed as a related topic, and MedlinePlus Genetics has been added under Related Topics.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded a Locations section listing North Carolina and removed the separate North Carolina Locations entry, with the page revision updated to v3.3.3.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedMelanoma and MedlinePlus Genetics-related topics were removed from the related topics section, but the study details, eligibility criteria, and results remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedThe Publications note on PubMed-generated lists was updated to indicate automatic PubMed population, and the Revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the generic government funding/status notice from the page. Study content, eligibility criteria, and trial logistics remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.